Meng‐Wei Zhuang

1.0k total citations
9 papers, 664 citations indexed

About

Meng‐Wei Zhuang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Meng‐Wei Zhuang has authored 9 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Meng‐Wei Zhuang's work include interferon and immune responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA regulation and disease (2 papers). Meng‐Wei Zhuang is often cited by papers focused on interferon and immune responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA regulation and disease (2 papers). Meng‐Wei Zhuang collaborates with scholars based in China, Germany and Hong Kong. Meng‐Wei Zhuang's co-authors include Pei‐Hui Wang, Jian Deng, Lulu Han, Yi Zheng, Chengjiang Gao, Mei‐Ling Nan, Jing Zhang, Xuejing Zhang, Jing Zhang and Li Wang and has published in prestigious journals such as Journal of the American Chemical Society, Cell Reports and Signal Transduction and Targeted Therapy.

In The Last Decade

Meng‐Wei Zhuang

9 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng‐Wei Zhuang China 8 369 286 212 107 73 9 664
Taisho Yamada Japan 6 173 0.5× 316 1.1× 220 1.0× 128 1.2× 29 0.4× 9 565
Carmon Kee Germany 8 406 1.1× 139 0.5× 146 0.7× 46 0.4× 109 1.5× 16 593
Vinícius Cardoso Soares Brazil 12 380 1.0× 131 0.5× 243 1.1× 19 0.2× 96 1.3× 18 648
Tapas Patra United States 14 166 0.4× 117 0.4× 211 1.0× 63 0.6× 64 0.9× 29 559
Yinglong She China 12 236 0.6× 131 0.5× 173 0.8× 44 0.4× 61 0.8× 16 551
Brigitte von Brunn Germany 7 251 0.7× 82 0.3× 140 0.7× 72 0.7× 48 0.7× 9 405
Bradley S. Barrett United States 15 140 0.4× 410 1.4× 217 1.0× 68 0.6× 18 0.2× 28 703
Kanupriya Whig United States 7 218 0.6× 137 0.5× 166 0.8× 24 0.2× 34 0.5× 15 396
Julie A. Cox Canada 13 93 0.3× 113 0.4× 316 1.5× 175 1.6× 37 0.5× 20 650
Dale J. Calleja Australia 7 169 0.5× 351 1.2× 285 1.3× 72 0.7× 12 0.2× 9 553

Countries citing papers authored by Meng‐Wei Zhuang

Since Specialization
Citations

This map shows the geographic impact of Meng‐Wei Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Wei Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Wei Zhuang more than expected).

Fields of papers citing papers by Meng‐Wei Zhuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Wei Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Wei Zhuang. The network helps show where Meng‐Wei Zhuang may publish in the future.

Co-authorship network of co-authors of Meng‐Wei Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Wei Zhuang. A scholar is included among the top collaborators of Meng‐Wei Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Wei Zhuang. Meng‐Wei Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hou, Jinxiu, Xuejing Zhang, Meng‐Wei Zhuang, et al.. (2025). IDR-driven TOLLIP condensates antagonize the innate antiviral immunity by promoting the deSUMOylation of MAVS. Cell Reports. 44(3). 115348–115348. 3 indexed citations
2.
Wang, Xiaotong, Xiaoyu Chen, Meng‐Wei Zhuang, et al.. (2023). Discovery and Characterization of a Myxobacterial Lanthipeptide with Unique Biosynthetic Features and Anti-inflammatory Activity. Journal of the American Chemical Society. 145(30). 16924–16937. 17 indexed citations
3.
Zheng, Yi, Jian Deng, Lulu Han, et al.. (2022). SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Signal Transduction and Targeted Therapy. 7(1). 22–22. 119 indexed citations
4.
Han, Lulu, Yi Zheng, Jian Deng, et al.. (2022). SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy. Journal of Medical Virology. 94(11). 5174–5188. 66 indexed citations
5.
Zhang, Yuehui, Limin Shang, Jing Zhang, et al.. (2021). An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. Cell chemical biology. 29(1). 5–18.e6. 29 indexed citations
6.
Han, Lulu, Meng‐Wei Zhuang, Jian Deng, et al.. (2021). SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways. Journal of Medical Virology. 93(9). 5376–5389. 182 indexed citations
7.
Zhuang, Meng‐Wei, Yun Cheng, Jing Zhang, et al.. (2020). Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection. Journal of Medical Virology. 92(11). 2693–2701. 136 indexed citations
8.
Zou, Jiahuan, Meng‐Wei Zhuang, Xiaopeng Yu, et al.. (2018). MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Molecular Immunology. 101. 203–209. 46 indexed citations
9.
Li, Na, Jianing Wang, Na Zhang, et al.. (2017). Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells. Cancer Immunology Immunotherapy. 67(2). 271–283. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026